BJA Advance Access published online on February 20, 2006
British Journal of Anaesthesia, doi:10.1093/bja/ael037
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Cardiothoracic and Vascular Anaesthesia and Intensive Care, University Hospital Vienna, Austria
* To whom correspondence should be addressed. Background. Magnesium is a calcium and an NMDA-receptor antagonist and can modify important mechanisms of nociception. We evaluated the co-analgesic effect of magnesium in the postoperative setting after on-pump cardiac surgery. Methods. Forty patients randomly received either magnesium gluconate as an i.v. bolus of 0.21 mmol kg-1 (86.5 mg kg-1) followed by a continuous infusion of 0.03 mmol-1 kg-1 h-1 (13.8 mg kg-1 h-1) or placebo for 12 h after tracheal extubation. After surgery, remifentanil was decreased to 0.05 µg kg-1 min-1 and titrated according to a pain intensity score (PIS, range 1-6) in the intubated, awake patient and a VAS scale (range 1-100) after extubation. If PIS was Results. Magnesium lowered the cumulative remifentanil requirement after surgery (P<0.05). PIS Conclusions. Magnesium gluconate moderately reduced the remifentanil consumption without serious side-effects. The opioid-sparing effect of magnesium may be greater at higher pain intensities and with increased dosages.
Accepted January 18, 2006
Clinical Investigation
Magnesium moderately decreases remifentanil dosage required for pain management after cardiac surgery
B. Steinlechner 1 *,
M. Dworschak 1,
B. Birkenberg 1,
G. Grubhofer 1,
M. Weigl 2,
A. Schiferer 1,
T. Lang 1,
and
A. Rajek 1
2 Division of General Anaesthesia and Intensive Care, University Hospital Vienna, Austria
B. Steinlechner, E-mail: barbara.steinlechner{at}meduniwien.ac.at
Abstract 
3 or VAS 30, the infusion was increased by 0.01 µg kg-1 min-1; if ventilatory frequency was 
10 min-1 it was decreased by the same magnitude.3 was more frequent in the placebo group (P<0.05). Despite increased remifentanil demand, VAS scores were also higher in the placebo group at 8 (2 vs 8) and 9 h after extubation (2 vs 7) (P<0.05). Dose reductions attributable to a ventilatory frequency 10 min-1 occurred more often in the magnesium group (17 vs 6; P<0.05). However, time to tracheal extubation was not prolonged.
Presented in part at the 79th Clinical and Scientific Meeting of the International Anaesthesia Research Society on March 11, 2005 in Honolulu, HI, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-H. Ryu, I.-S. Sohn, and S.-H. Do Controlled hypotension for middle ear surgery: a comparison between remifentanil and magnesium sulphate Br. J. Anaesth., October 1, 2009; 103(4): 490 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lysakowski, L. Dumont, C. Czarnetzki, and M. R. Tramer Magnesium as an Adjuvant to Postoperative Analgesia: A Systematic Review of Randomized Trials Anesth. Analg., June 1, 2007; 104(6): 1532 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Larson, P. D. Berry, J. May, A. Bjorksten, and D. I. Sessler Autonomic effects of epidural and intravenous fentanyl Br. J. Anaesth., February 1, 2007; 98(2): 263 - 269. [Abstract] [Full Text] [PDF]
|
|